Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Purple Biotech Says It Completed Patient Enrollment in Phase 2 Pancreatic Cancer Trial; Primary Endpoint Of The Study Is Expected During 1H 2024 And Topline Analysis Is Expected In 2H 2024

Author: Benzinga Newsdesk | December 14, 2023 07:53am

Posted In: PPBT